Shopping Cart
- Remove All
- Your shopping cart is currently empty
β-Cateninmodulator-7 (Compound 5) acts as a regulator of β-catenin. It suppresses the expression of β-catenin in both the cytoplasm and nucleus of HCT-116 cells and inhibits the phosphorylation of GSK 3β. Additionally, β-Cateninmodulator-7 facilitates the release of NO in HCT-116 cells and inhibits the proliferation of these cancer cells, with an IC50 value of 0.6-0.9 μM. This compound is utilized in research related to colon cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | β-Cateninmodulator-7 (Compound 5) acts as a regulator of β-catenin. It suppresses the expression of β-catenin in both the cytoplasm and nucleus of HCT-116 cells and inhibits the phosphorylation of GSK 3β. Additionally, β-Cateninmodulator-7 facilitates the release of NO in HCT-116 cells and inhibits the proliferation of these cancer cells, with an IC50 value of 0.6-0.9 μM. This compound is utilized in research related to colon cancer. |
Molecular Weight | 583.03 |
Formula | C26H35ClN4O9 |
Cas No. | 2892294-93-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.